|
|
|||||||||||
1 Research Center, Rockland State Hospital, Orangeburg, N.Y. 10962, U.S.A.
Thirty-eight chronic schizophrenic in-patients participated in a double blind crossover comparison of once-daily versus thrice-daily administered thiothixene. The once-daily dose was given at bed-time. Improvement over the placebo baseline occurred with both regimens though it appeared somewhat sooner with the multiple dosage regimen. During the final maintenance phase of the trial there was no difference between the regimens. Extrapyramidal side effects were consistently more marked with the multiple dosage regimen, though the difference reached statistical significance on only a few occasions. The practical applications of these findings are discussed, particularly in terms of maintenance therapy for both in-patients and out-patients and of the possibility of improving prescription compliance in the latter.
Submitted on August 13, 1973
This article has been cited by other articles:
![]() |
T. B. Cooper, G. M. Simpson, E. J. Haher, and P.-E. E. Bergner Butaperazine Pharmacokinetics: Effect of Dosage Regimen on Steady State Blood Levels Arch Gen Psychiatry, July 1, 1975; 32(7): 903 - 905. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |